Tumor-specific methylations in circulating cell-free DNA as clinically applicable markers with potential to substitute mutational analyses
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor-specific methylations in circulating cell-free DNA as clinically applicable markers with potential to substitute mutational analyses
Authors
Keywords
-
Journal
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
Volume 18, Issue 12, Pages 1011-1019
Publisher
Informa UK Limited
Online
2018-11-09
DOI
10.1080/14737159.2018.1545576
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study
- (2018) Julia Bergheim et al. BRITISH JOURNAL OF CANCER
- Mutation and Methylation Analysis of Circulating Tumor DNA Can Be Used for Follow-up of Metastatic Colorectal Cancer Patients
- (2018) Nele Boeckx et al. Clinical Colorectal Cancer
- Cell-Free Circulating Methylated SEPT9 for Noninvasive Diagnosis and Monitoring of Colorectal Cancer
- (2018) Bo Fu et al. DISEASE MARKERS
- Evaluation of bisulfite kits for DNA methylation profiling in terms of DNA fragmentation and DNA recovery using digital PCR
- (2018) Sam Kint et al. PLoS One
- Epigenetic markers in circulating cell-free DNA as prognostic markers for survival of castration-resistant prostate cancer patients
- (2018) Rianne J. Hendriks et al. PROSTATE
- Detection and localization of surgically resectable cancers with a multi-analyte blood test
- (2018) Joshua D. Cohen et al. SCIENCE
- Circulating tumour DNA for monitoring colorectal cancer—a prospective cohort study to assess relationship to tissue methylation, cancer characteristics and surgical resection
- (2018) Erin L. Symonds et al. Clinical Epigenetics
- Circulating DNA-based lung cancer diagnostics and follow-up: looking for epigenetic markers
- (2018) Elena Y. Rykova et al. Translational Cancer Research
- Epigenetic Modifications as Biomarkers of Tumor Development, Therapy Response, and Recurrence across the Cancer Care Continuum
- (2018) Margaret Thomas et al. Cancers
- Comparative analysis of 12 different kits for bisulfite conversion of circulating cell-free DNA
- (2017) Mai-Britt Worm Ørntoft et al. Epigenetics
- Droplet-based digital PCR and next generation sequencing for monitoring circulating tumor DNA: a cancer diagnostic perspective
- (2017) Mathilde Postel et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications
- (2017) Anna-Lena Volckmar et al. GENES CHROMOSOMES & CANCER
- Methylated free-circulatingHPP1DNA is an early response marker in patients with metastatic colorectal cancer
- (2017) Andreas Herbst et al. INTERNATIONAL JOURNAL OF CANCER
- Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study
- (2017) Kala Visvanathan et al. JOURNAL OF CLINICAL ONCOLOGY
- Mutations in TP53 , PIK3CA , PTEN and other genes in EGFR mutated lung cancers: Correlation with clinical outcomes
- (2017) Paul A. VanderLaan et al. LUNG CANCER
- Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA
- (2017) Shicheng Guo et al. NATURE GENETICS
- Cell‐Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta‐Analysis
- (2017) Karen‐Lise G. Spindler et al. ONCOLOGIST
- Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer
- (2017) John H. Strickler et al. Cancer Discovery
- LINE-1 hypomethylation status of circulating cell-free DNA in plasma as a biomarker for colorectal cancer
- (2017) Yuzo Nagai et al. Oncotarget
- Comparison of quantification algorithms for circulating cell-free DNA methylation biomarkers in blood plasma from cancer patients
- (2017) Luka de Vos et al. Clinical Epigenetics
- A Study of Hypermethylated Circulating Tumor DNA as a Universal Colorectal Cancer Biomarker
- (2016) S. Garrigou et al. CLINICAL CHEMISTRY
- Methylated circulating tumor DNA in blood: power in cancer prognosis and response
- (2016) Kristina Warton et al. ENDOCRINE-RELATED CANCER
- Optimizing adjuvant therapy and survivorship care of stage III colon cancer
- (2016) Jonathan M Loree et al. Future Oncology
- Epigenetic Homogeneity Within Colorectal Tumors Predicts Shorter Relapse-Free and Overall Survival Times for Patients With Locoregional Cancer
- (2016) Anna Martínez-Cardús et al. GASTROENTEROLOGY
- Hypomethylation of human-specific family of LINE-1 retrotransposons in circulating DNA of lung cancer patients
- (2016) Ildar V. Gainetdinov et al. LUNG CANCER
- Translating neoadjuvant therapy into survival benefits: one size does not fit all
- (2016) Leticia De Mattos-Arruda et al. Nature Reviews Clinical Oncology
- Identification of tissue-specific cell death using methylation patterns of circulating DNA
- (2016) Roni Lehmann-Werman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Quantification of Unmethylated Alu (QUAlu): a tool to assess global hypomethylation in routine clinical samples
- (2016) Raquel Buj et al. Oncotarget
- Experimental factors affecting the robustness of DNA methylation analysis
- (2016) Heidi D. Pharo et al. Scientific Reports
- Digital PCR quantification ofMGMTmethylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer
- (2015) L. Barault et al. ANNALS OF ONCOLOGY
- High-resolution characterization of sequence signatures due to non-random cleavage of cell-free DNA
- (2015) Dineika Chandrananda et al. BMC Medical Genomics
- Genomic Classification of Cutaneous Melanoma
- (2015) Rehan Akbani et al. CELL
- Controls to validate plasma samples for cell free DNA quantification
- (2015) Niels Pallisgaard et al. CLINICA CHIMICA ACTA
- Improved sensitivity of circulating tumor DNA measurement using short PCR amplicons
- (2015) Rikke Fredslund Andersen et al. CLINICA CHIMICA ACTA
- Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
- (2015) Giulia Siravegna et al. NATURE MEDICINE
- The influence of subclonal resistance mutations on targeted cancer therapy
- (2015) Michael W. Schmitt et al. Nature Reviews Clinical Oncology
- Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments
- (2015) Kun Sun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
- (2015) Peiyong Jiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Quantification of Cell-Free mSHOX2 Plasma DNA for Therapy Monitoring in Advanced Stage Non-Small Cell (NSCLC) and Small-Cell Lung Cancer (SCLC) Patients
- (2015) Bernd Schmidt et al. PLoS One
- Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer
- (2014) K L Mahon et al. BRITISH JOURNAL OF CANCER
- Novel Methylated Biomarkers and a Robust Assay to Detect Circulating Tumor DNA in Metastatic Breast Cancer
- (2014) Mary Jo Fackler et al. CANCER RESEARCH
- Circulating Tumor DNA as a Liquid Biopsy for Cancer
- (2014) E. Heitzer et al. CLINICAL CHEMISTRY
- Leukocyte-adjusted epigenome-wide association studies of blood from solid tumor patients
- (2014) Scott M Langevin et al. Epigenetics
- Liquid Biopsies: Genotyping Circulating Tumor DNA
- (2014) Luis A. Diaz et al. JOURNAL OF CLINICAL ONCOLOGY
- KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer
- (2013) K G Spindler et al. BRITISH JOURNAL OF CANCER
- Companion Biomarkers: Paving the Pathway to Personalized Treatment for Cancer
- (2013) M. J. Duffy et al. CLINICAL CHEMISTRY
- Potentialities of aberrantly methylated circulating DNA for diagnostics and post-treatment follow-up of lung cancer patients
- (2013) Anastasia A. Ponomaryova et al. LUNG CANCER
- Liquid biopsy: monitoring cancer-genetics in the blood
- (2013) Emily Crowley et al. Nature Reviews Clinical Oncology
- Determinants of nucleosome positioning
- (2013) Kevin Struhl et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Methods for Applying Accurate Digital PCR Analysis on Low Copy DNA Samples
- (2013) Alexandra S. Whale et al. PLoS One
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- Serum DNA methylation for monitoring response to neoadjuvant chemotherapy in breast cancer patients
- (2012) Ayelet Avraham et al. INTERNATIONAL JOURNAL OF CANCER
- AIM1 and LINE-1 Epigenetic Aberrations in Tumor and Serum Relate to Melanoma Progression and Disease Outcome
- (2012) Sojun Hoshimoto et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Evolution of the cancer genome
- (2012) Lucy R. Yates et al. NATURE REVIEWS GENETICS
- DNA methylation profiling in the clinic: applications and challenges
- (2012) Holger Heyn et al. NATURE REVIEWS GENETICS
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Role of DNA Methylation in Aging, Rejuvenation, and Age-Related Disease
- (2012) Adiv A. Johnson et al. REJUVENATION RESEARCH
- DNA methylation of circulating DNA: a marker for monitoring efficacy of neoadjuvant chemotherapy in breast cancer patients
- (2012) Gayatri Sharma et al. TUMOR BIOLOGY
- Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer
- (2011) Cecily P. Vaughn et al. GENES CHROMOSOMES & CANCER
- Adjuvant Chemotherapy for Stage II Colon Cancer With Poor Prognostic Features
- (2011) Erin S. O'Connor et al. JOURNAL OF CLINICAL ONCOLOGY
- Increased methylation variation in epigenetic domains across cancer types
- (2011) Kasper Daniel Hansen et al. NATURE GENETICS
- Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina–associated domains
- (2011) Benjamin P Berman et al. NATURE GENETICS
- Methylation patterns in cell-free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patients
- (2010) Thomas E. Liggett et al. INTERNATIONAL JOURNAL OF CANCER
- First-line therapy and methylation status of CHFR in serum influence outcome to chemotherapy versus EGFR tyrosine kinase inhibitors as second-line therapy in stage IV non-small-cell lung cancer patients
- (2010) Fernanda Salazar et al. LUNG CANCER
- Relationship between nucleosome positioning and DNA methylation
- (2010) Ramakrishna K. Chodavarapu et al. NATURE
- Methylated DAPK and APC promoter DNA detection in peripheral blood is significantly associated with apparent residual tumor and outcome
- (2009) Andreas-Claudius Hoffmann et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Sensitive digital quantification of DNA methylation in clinical samples
- (2009) Meng Li et al. NATURE BIOTECHNOLOGY
- MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
- (2009) Michael Weller et al. Nature Reviews Neurology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started